Found vs Thryve
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Found and Thryve are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Found starts at $149/mo, and Found edges ahead overall (8.3 vs 3.3 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.
Pricing
Found
$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.
Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.
'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.
Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.
Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.
Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.
Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.
Thryve
Pricing not publicly listed.
Get alerted when GLP-1 prices drop
Join the GLP-1 price-watch list — we re-verify 430+ providers' prices on their own sites and email you when tracked prices move.
What’s included
Found
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
Thryve
Inclusions not disclosed.
Score breakdown
Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.
Found
8.3/10
Thryve
3.3/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
Features & Coverage
| Feature | Found | Thryve |
|---|---|---|
| Starting Price | $149/mo | — |
| Features | 3 features | 3 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
About Found
Personalized weight care platform with a self-pay membership model plus medication costs.
Read our full Found review →About Thryve
Thryve markets a GLP-1 peptide program for weight loss, starting at $99 a month. The site does not name a specific medication such as semaglutide or tirzepatide, describing its product only as "a peptide currently under clinical research." As of this review the site has no working Terms of Service or Privacy Policy page, and its "Get Started" button does not lead to any signup or intake flow.
Read our full Thryve review →Pros & Cons
Found
What we like
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Thryve
What we like
- Advertises a straightforward starting price of $99/month on the homepage
- States a weight-loss money-back guarantee on the homepage banner
Watch-outs
- Does not name the specific medication (e.g., semaglutide, tirzepatide) anywhere on the site
- No working Terms of Service or Privacy Policy page — the footer links have empty hrefs
- No functional signup or intake flow found — the "Get Started" button links to an in-page anchor with no matching content
- Lists a placeholder phone number (tel:+123 12345 67890) instead of real contact info
- No state-availability, pharmacy-partner, or legal-entity information published
- Site's own sitemap shows only the homepage and the default WordPress "Hello World" post
- "Trusted by 20,000+ Members" and a 5-star badge are not linked to any verifiable review platform
- Describes its product only as "a peptide currently under clinical research," not as an FDA-approved medication
Our Verdict
Found edges out Thryve with a higher overall score of 8.3/10 and is particularly strong for mainstream telehealth GLP-1 access. Thryve remains a solid alternative.
Choose Found if…
You want mainstream telehealth GLP-1 access and a starting price around $149/mo.
Ready to start? Vetted GLP-1 providers
Vetted telehealth providers that prescribe GLP-1 online.
No insurance needed · vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
GobyMeds
Budget-conscious shoppers
From $93/mo
Get started →Direct Meds
Listed for disclosure only — see its FDA warning and BBB complaints first
From $249/mo
Get started →Maximus
Men seeking compounded GLP-1 alongside testosterone optimization
From $199.99/mo
Get started →Found vs Thryve: FAQ
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Related comparisons
Continue exploring Found and Thryve head-to-heads in the same category.
- Found vs Amazon One Medical
- Found vs Vytora Health
- Found vs CoreAge Rx
- Thryve vs EverSlim
- Thryve vs NewSelf
- Thryve vs Elara Health and Wellness
Or see the full category ranking.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.